221 related articles for article (PubMed ID: 23492738)
1. Small molecular compounds in development for rheumatoid arthritis.
van Vollenhoven RF
Curr Opin Rheumatol; 2013 May; 25(3):391-7. PubMed ID: 23492738
[TBL] [Abstract][Full Text] [Related]
2. Novel small-molecular therapeutics for rheumatoid arthritis.
Fleischmann R
Curr Opin Rheumatol; 2012 May; 24(3):335-41. PubMed ID: 22357358
[TBL] [Abstract][Full Text] [Related]
3. Selective JAK inhibitors in development for rheumatoid arthritis.
Norman P
Expert Opin Investig Drugs; 2014 Aug; 23(8):1067-77. PubMed ID: 24818516
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Janus kinases in rheumatoid arthritis: focus on tofacitinib.
Yamaoka K; Tanaka Y
Expert Opin Pharmacother; 2014 Jan; 15(1):103-13. PubMed ID: 24188100
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase inhibitors for rheumatoid arthritis.
Yamaoka K
Curr Opin Chem Biol; 2016 Jun; 32():29-33. PubMed ID: 26994322
[TBL] [Abstract][Full Text] [Related]
6. Kinase inhibitors: the next generation of therapies in the treatment of rheumatoid arthritis.
MacFarlane LA; Todd DJ
Int J Rheum Dis; 2014 May; 17(4):359-68. PubMed ID: 24460872
[TBL] [Abstract][Full Text] [Related]
7. Promising new treatments for rheumatoid arthritis - the kinase inhibitors.
Yazici Y; Regens AL
Bull NYU Hosp Jt Dis; 2011; 69(3):233-7. PubMed ID: 22035435
[TBL] [Abstract][Full Text] [Related]
8. Developments with investigational Janus kinase inhibitors for rheumatoid arthritis.
Semerano L; Decker P; Clavel G; Boissier MC
Expert Opin Investig Drugs; 2016 Dec; 25(12):1355-1359. PubMed ID: 27748152
[No Abstract] [Full Text] [Related]
9. [JAK inhibitor].
Yamaoka K; Tanaka Y
Nihon Rinsho; 2013 Jul; 71(7):1243-7. PubMed ID: 23961674
[TBL] [Abstract][Full Text] [Related]
10. Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis.
Iwata S; Tanaka Y
Expert Rev Clin Immunol; 2016 Oct; 12(10):1047-57. PubMed ID: 27253519
[TBL] [Abstract][Full Text] [Related]
11. Baricitinib: JAK inhibition for rheumatoid arthritis.
Gras J
Drugs Today (Barc); 2016 Oct; 52(10):543-550. PubMed ID: 27910962
[TBL] [Abstract][Full Text] [Related]
12. JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy.
Vaddi K; Luchi M
Expert Opin Investig Drugs; 2012 Jul; 21(7):961-73. PubMed ID: 22612502
[TBL] [Abstract][Full Text] [Related]
13. Kinase inhibitors: a new approach to rheumatoid arthritis treatment.
Cohen S; Fleischmann R
Curr Opin Rheumatol; 2010 May; 22(3):330-5. PubMed ID: 20164774
[TBL] [Abstract][Full Text] [Related]
14. New drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors.
Bonilla-Hernán MG; Miranda-Carús ME; Martin-Mola E
Rheumatology (Oxford); 2011 Sep; 50(9):1542-50. PubMed ID: 21622522
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib for treatment of rheumatoid arthritis.
Rakieh C; Conaghan PG
Adv Ther; 2013 Aug; 30(8):713-26. PubMed ID: 23943546
[TBL] [Abstract][Full Text] [Related]
16. Peficitinib: First Global Approval.
Markham A; Keam SJ
Drugs; 2019 Jun; 79(8):887-891. PubMed ID: 31093950
[TBL] [Abstract][Full Text] [Related]
17. [A new therapeutical option for chronic inflammation in rheumatology: janus kinases inhibitors (JAK)].
Varisco PA; So A
Rev Med Suisse; 2014 Jan; 10(414):187-91. PubMed ID: 24624736
[TBL] [Abstract][Full Text] [Related]
18. Kinase inhibitors: a new class of antirheumatic drugs.
Kyttaris VC
Drug Des Devel Ther; 2012; 6():245-50. PubMed ID: 23055694
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis.
Tanaka Y; Maeshima K; Yamaoka K
Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i70-4. PubMed ID: 22460142
[TBL] [Abstract][Full Text] [Related]
20. Emerging therapies for rheumatoid arthritis.
Jacques P; Van den Bosch F
Expert Opin Emerg Drugs; 2013 Jun; 18(2):231-44. PubMed ID: 23725568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]